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Suk Ju Cho1, Su Wan Kim2* and Jee Won Chang2Abstract
Chemical pleurodesis is widely recommended in the treatment of pulmonary air leak of different etiologies as well
as malignant pleural effusions and chylothorax. Conventional chemical pleurodesis using erythromycin, tetracycline,
hydrophilic fumed silica, autologous blood and talc slurry has been standardized, and its complications, including
high fever, intractable chest pain, and acute lung injury, seem to be frequent. Viscum album extract is a new
chemical agent for pleurodesis, and only a few studies have reported outcomes of such chemical pleurodesis in the
treatment of malignant pleural effusion. Moreover, the complications resulting from pleurodesis using Viscum album
extract are very rare, and acute pneumonitis has not been reported. in this paper we report the first case of acute
pneumonitis after pleurodesis using Viscum album extract in a 58-year-old man who had prolonged air leaks after a
left upper lingularsegmentectomy for metastatic lung cancer. We performed repeated pleurodesis four times with 2
to 4 days intervals. While the patient had no symptoms of pneumonia, such as cough, sputum, chilling, and fatigue,
a follow-up chest X-ray revealed increasing peribronchial consolidations and infiltrations in the left upper lobe. A
chest tomography showed extensive parenchymal consolidations and ground-glass appearances in the left lungs,
representing pneumonia with acute lung injury. The acute pneumonitis was spontaneously resolved with supportive
care, and the patient was discharged ten days after the development of pneumonitis. We think that pleurodesis with
Viscum album extract is effective, but repeated pleurodesis should be avoided for possible onset of acute pneumonitis.
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Acute pneumonitis is a frequent problem that has a
great impact on the quality of life of patients treated
with pleurodesis. It has been suggested that acute pneu-
monitis has been caused by pulmonary deposition and
trans-pleural absorption of the sclerosing agents, such as
tetracyclin, bleomycin, and talc, and it occurs through
lymphatic stomata, whose openings are distributed in the
parietal pleural [1]. However, the pathophysiologic mechan-
ism responsible for this severe complication is still unclear.
To date, most therapeutic options have been limited to sup-
portive care. Viscum album extract from European mistle-
toe contains a number of biologically active compounds,* Correspondence: 95swan@hanmail.net
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unless otherwise stated.mainly the mistletoe lectins, viscotoxins, and other low mo-
lecular weight proteins, which exert immune-modulatory,
cytotoxic, apoptotic, and anti-angiogenic effects [2]. This
extract is the most frequently prescribed drug for comple-
mentary treatment in cancer patients in several European
countries. However, only a few studies have reported out-
comes after its use for chemical pleurodesis in the treat-
ment of malignant pleural effusion [3-5] and any serious
side effect, such as acute pneumonitis, has not been de-
scribed yet. We hereby report the first case of acute pneu-
monitis, an unusual complication after pleurodesis with
Viscum album extract.Case presentation
A 58-year-old male patient, who had undergone a left
nephrectomy for renal cell carcinoma five years before,
was admitted to our department because a routine chest
CT showed a pulmonary solitary nodule. Chest X-ray. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.mrmjournal.com/content/9/1/61and CT revealed a well-circumscribed mass in the left
middle lung field that was suspicious for metastatic lung
cancer (Figure 1A,B). We performed a lingular segmen-
tectomy through a thoracotomy. The patient had an in-
complete fissure between the upper and lower lobes, and
we used two auto-stapling devices to separate the fissure.
We inserted two chest tube drainages and then closed
the thoracotomy. The post-operative course was compli-
cated by persistent air leakage resulting in collapse of
the left lung, as shown in Figure 1C. While we added a
chest tube four days after the operation and kept drain-
age with negative pressure, the lungs could not be fully
expanded (Figure 1D).
We underwent a chemical pleurodesis using an extract
of Viscum album (European mistletoe) (ABNOBA viscum
F®, ABNOBA Heilmittel GmbH, Pforzheim, Germany) six
days after the operation. We mixed five ampoules of
ABNOBA viscum F® (100 mg) and 200 ml normal saline,
and injected them through the chest tube. We repeated
the pleurodesis eight days and twelve days after the oper-
ation with the same method. Then we removed one chest
tube because of decreasing amount of air leakage. The
fourth pleurodesis was performed sixteen days after the
operation. Unfortunately, a follow- up chest X-ray showed
increasing extents of peribronchial consolidations and in-
filtrations in the left upper lung (Figure 2A). A chest CTFigure 1 Peri-operative X-ray findings. Chest X-ray (A) and computed tom
air leakage results in collapse of the left lungs (C). While we added a chest tubrevealed extensive parenchymal consolidations in the
whole left lung, air-fluid levels within the emphysema-
tous bullae, and multiple reactive mediastinal lymph
nodes; all of these findings indicated a suspicious of
pneumonia (Figure 2B,C, and D).
On the other hand, the patient had no subjective symp-
toms, such as febrile sense, dyspnea, cough, and sputum.
An arterial blood gas analysis revealed a pH of 7.39, a
PaCO2 of 39.7 mmHg, a PaO2 of 87 mmHg, and oxygen
saturation of 93.1% on nasal prong oxygen 2 L/min. A
white blood cell count was 17,200 /uL with 78.6 % of seg-
mented neutrophil. C-reactive protein was 30.5 mg/dl,
and procalcitonin level was 2.94 mg/dL. Blood chemistry
showed serum creatinine of 1.6 mg/dL, potassium of
5.7 mmol/L, serum albumin of 2.9 mg/dL, and alanine
transaminase of 16 IU/L. We performed a supportive care
including oxygen inhalation, mucolytics, diuretics, and
empirical antibiotics (moxifloxacin). Five days after the
supportive care, a follow- up chest X-ray showed markedly
decreased pulmonary infiltrations, and the remaining
chest tube was removed (Figure 3A). The patient was fully
recovered from the acute pneumonitis with normalized la-
boratory findings and oxygen saturation of 98% at room
air. The patient was discharged twenty-six days after the
segmentectomy and followed-up for four months without
any respiratory symptoms (Figure 3B).ography (B) show a metastatic lung cancer. A post-operative persistent
e, the lungs could not be fully expanded (D).
Figure 2 Images of acute pneumonitis. A follow-up chest X-ray shows increasing extents of peribronchial consolidations and infiltrations in the
left upper lung (A). A chest computed tomography reveals extensive parenchymal consolidations in the whole left lungs, air-fluid levels within
the emphysematous bullae, and multiple reactive mediastinal lymph nodes; all of these findings indicated a suspicious of pneumonia (B, C, D).
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Prolonged air leak is one of the most common post-
operative complications encountered after thoracic sur-
gery that involves that involves mobilization or pulmonary
resection. It is an important complication that results in
an increased hospital stay for prolonged chest tube drain-
age and is associated with other post-operative complica-
tions, such as thoracic pain, pneumonia and respiratory
distress [6,7]. Rena et al. suggested that a routine use of
surgical staplers, even buttressed by synthetic or organic
strips, does not result in an adequate air sealing in mostFigure 3 X-ray findings of resolving the acute pneumonitis. A follow-u
as the remaining chest tube was removed (A). The patient was discharged
months without any respiratory symptoms (B).patients undergoing pulmonary lobectomy [8]. When an
air leak persists after pulmonary lobectomy, a bronchos-
copy is generally recommended to rule out broncho-
pleural fistula. A significant broncho-pleural fistula should
be corrected by surgical intervention, including re-closure
of bronchial stump and reinforcement with surrounding
pericardium, muscle, or soft tissue. We performed bron-
choscopy two days after segmentectomy for prolonged air
leakage. There was no evidence of broncho-pleural fistula.
However, lots of blood-tingled secretions in the bronchial
stump and inflammatory changes were observed. Afterp chest X-ray showed a markedly decreased pulmonary infiltrations so
twenty-six days after the segmentectomy and followed- up for four
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http://www.mrmjournal.com/content/9/1/61removing the secretions, the left lower lobe appeared to
be slightly re-expanded. The left lung was re-collapsed the
next day. Although we added a chest tube four days after
the operation and kept drainage with negative pressure,
the left lung could not be fully expanded. Therefore, we
decided to perform chemical pleurodesis.
Chemical pleurodesis is widely recommended in the
treatment of pulmonary air leak of different etiologies as
well as malignant pleural effusions and chylothorax
[7,9-11]. Instillation of a sclerosing agent into the pleural
space elicits an inflammatory reaction in the pleura that al-
lows for the obliteration of the pleural space and resolution
of an air leak or pleural effusion. Numerous sclerotic
agents, including erythromycin, tetracycline, hydrophilic
fumed silica, autologous blood and talc slurry [9,12-14]
have been used to produce pleural symphysis, and several
studies have investigated the efficacy and complications of
them. Reported usual minor complications of pleurodesis
are high fever, severe pain, tachycardia, and dyspnea. While
talc is the most commonly used sclerosing agent and
known to be the most effective material, there have been
variable reports of its serious complications, such as pul-
monary edema, acute pneumonitis, and acute respiratory
distress syndrome [15-18]. For these reasons, several inves-
tigations to search for new agents for pleurodesis are on-
going. Byun et al. researched effects of taurolidine and
proposed that it is an effective alternative agent for the
management of pulmonary air leakage [19]. Godazandeh
et al. and other researchers suggested that povidone-iodine
is an effective, inexpensive, safe and feasible agent for
chemical pleurodesis in the management of malignant
pleural effusion [20]. These new agents seem to need
further investigation because there was a report about
serious complication of visual loss after pleurodesis
using povidone-iodine [21].
ABNOBA viscum F® is an extract of Viscum album
(European mistletoe) which grows on trees of the genus
Fraxinus. This extract is the most frequently prescribed
drug for complementary treatment in cancer patients in
several European countries. It is known to stimulate the
immune system, improve survival, enhanc equality of
life, and decrease the side effects of chemotherapy and
radiotherapy [22,23]. However, only few studies have re-
ported outcomes after its use for chemical pleurodesis in
the treatment of malignant pleural effusion [3-5] and
congenital chylothorax [24]. Furthermore, these studies
do not report any serious complications, only slight side
effects such as mild febrile sense, scanty burning, and
loculated effusion.
In our case, while the images of the acute pneumonitis
revealed grave findings that resembled acute respiratory
distress syndrome, the patient presented no subjective
symptom. The supportive cares, including oxygen inhal-
ation, mucolytics, diuretics, and empirical antibiotics, couldfully recover the patient ten days after the acute pneumon-
itis. We repeated pleurodesis four times with 2 or 4 days
intervals and mixed five ampoules of ABNOBA viscum F®
(100 mg) and 200 ml normal saline, and we injected them
through the chest tube. The dosage of Viscum album ex-
tract was selected based on the dosage for adults with a
body weight of 60 Kg. The usual starting dose is 100 mg
and it can be increased to 500 mg [3,5]. Because the dosage
has a wide range, we suggest that the dosage should not re-
sult in an acute pneumonitis. We suppose that the interval
of repeated pleurodesis is potentially related to the acute
pneumonitis.
Conclusions
A pleurodesis with Viscum album extract, for patients with
malignant pleural effusion and prolonged air leakage after
lung resection and chylothoraxm, seems to be effective. We
propose that, when repeated pleurodesis is mandatory,
pleurodesis with Viscum album extract should be per-
formed with careful attention and at sufficient intervals
over one week. If an acute pneumonitis occurs, it can be
spontaneously and quickly resolved with supportive care.
However, there are not enough data in literature to prove
the efficacy or to represent complications of the pleurodesis
using Viscum album extract. We believe that a treatment
strategy for pleurodesis using Viscum album extract can be
feasible after further variable and intensified studies.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Anesthesiology and Pain Medicine, Jeju National University
Hospital, Jeju National University School of Medicine, Jeju, Korea.
2Department of Thoracic and Cardiovascular Surgery, Jeju National University
Hospital, Jeju National University School of Medicine, Aran 13 gil 15, Jeju-si,
Jeju Special Self-Governing Province 690-767, Korea.
Received: 27 August 2014 Accepted: 17 October 2014
Published: 27 November 2014
References
1. Montes JF, Ferrer J, Villarino MA, Baeza B, Crespo M, Garcia-Valero J: Influence
of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J
Respir Crit Care Med 2003, 168:348–355.
2. Kienle GS, Kiene H: Review article: influence of Viscum album L (European
mistletoe) extracts on quality of life in cancer patients: a systematic
review of controlled clinical studies. Integr Canc Ther 2010, 9:142–157.
3. Stumpf C, Bussing A: Stimulation of antitumour immunity by intrapleural
instillation of a Viscum album L. extract. Anti-Cancer Drugs 1997,
8(Suppl 1):S23–S26.
4. Salzer G, Muller H: Topical treatment of malignant pleural effusions with
iscador, a mistletoe preparation (author’s transl). Praxis Klin Pneumol 1978,
32:721–729.
Cho et al. Multidisciplinary Respiratory Medicine 2014, 9:61 Page 5 of 5
http://www.mrmjournal.com/content/9/1/615. Salzer G: The local treatment of malignant pleural exudations with Iscador
(a drug obtained from Misteltoe). Preliminary report (author's transl). Oster Z
Onkol 1977, 4:13–14.
6. How CH, Tsai TM, Kuo SW, Huang PM, Hsu HH, Lee JM, Chen JS, Lai HS:
Chemical pleurodesis for prolonged postoperative air leak in primary
spontaneous pneumothorax. J Formos Med Assoc 2014, 113:284–290.
7. Cerfolio RJ, Tummala RP, Holman WL, Zorn GL, Kirklin JK, McGiffin DC, Naftel
DC, Pacifico AD: A prospective algorithm for the management of air leaks
after pulmonary resection. Ann Thorac Surg 1998, 66:1726–1731.
8. Rena O, Papalia E, Mineo TC, Massera F, Pirondini E, Turello D, Casadio C:
Air-leak management after upper lobectomy in patients with fused
fissure and chronic obstructive pulmonary disease: a pilot trial
comparing sealant and standard treatment. Interact Cardiovasc Thorac
Surg 2009, 9:973–977.
9. Marchi E, Vargas FS, Madaloso BA, Carvalho MV, Terra RM, Teixeira LR:
Pleurodesis for malignant pleural effusions: a survey of physicians in
South and Central America. J Bras Pneumol 2010, 36:759–767.
10. Buyukates M, Turan SA, Altunkaya SA: Talc pleurodesis in the treatment of
chylothorax following mitral valve replacement. J Cardiovasc Surg 2007,
48:395–396.
11. Matthys H: Spontaneous pneumothorax. Multidiscip Respir Med 2011, 6:6–7.
12. Hashemzadeh S, Hashemzadeh K, Mamaghani K, Ansari E, Aligholipour R,
Golzari SE, Ghabili K: Pleurodesis by erythromycin, tetracycline, Aerosil
200, and erythromycin plus Aerosil 200 in a rat model: a preliminary
study. Daru 2012, 20:79.
13. Cobanoglu U, Melek M, Edirne Y: Autologous blood pleurodesis: a good
choice in patients with persistent air leak. Ann Thorac Med 2009, 4:182–186.
14. Shackcloth MJ, Poullis M, Jackson M, Soorae A, Page RD: Intrapleural
instillation of autologous blood in the treatment of prolonged air leak
after lobectomy: a prospective randomized controlled trial. Ann Thorac
Surg 2006, 82:1052–1056.
15. Scalzetti EM: Unilateral pulmonary edema after talc pleurodesis. J Thorac
Imaging 2001, 16:99–102.
16. Brant A, Eaton T: Serious complications with talc slurry pleurodesis.
Respirology 2001, 6:181–185.
17. Rehse DH, Aye RW, Florence MG: Respiratory failure following talc
pleurodesis. Am J Surg 1999, 177:437–440.
18. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C: Acute pneumonitis
with bilateral pleural effusion after talc pleurodesis. Chest 1984,
86:795–797.
19. Byun CS, Park IK, Shim HS, Bae MK, Lee CY, Chung KY: Taurolidine: a new
alternative agent for the management of the postoperative air leak.
Ann Thorac Cardiovasc Surg 2013, 19:6–11.
20. Godazandeh G, Qasemi NH, Saghafi M, Mortazian M, Tayebi P: Pleurodesis
with povidone-iodine, as an effective procedure in management of
patients with malignant pleural effusion. J Thorac Dis 2013, 5:141–144.
21. Wagenfeld L, Zeitz O, Richard G: Visual loss after povidone-iodine
pleurodesis. N Engl J Med 2007, 357:1264–1265.
22. Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B: Efficacy and
safety of long-term complementary treatment with standardized
European mistletoe extract (Viscum album L.) in addition to the
conventional adjuvant oncologic therapy in patients with primary
non-metastasized mammary carcinoma. Results of a multi-center,
comparative, epidemiological cohort study in Germany and Switzerland.
Arzneimittelforschung 2004, 54:456–466.
23. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M: Mistletoe therapy
in oncology. Cochrane Database. Syst Rev 2008, CD003297.
24. Cho HJ, Na KJ, Kim do W, Choi YE, Ma JS, Jeong IS: Chemical pleurodesis
using a Viscum album extract in infants with congenital chylothorax.
Eur J Pediatr 2014, 173:823–826.
doi:10.1186/2049-6958-9-61
Cite this article as: Cho et al.: Acute pneumonitis consequent on
pleurodesis with Viscum album extract: severe chest images but benign
clinical course. Multidisciplinary Respiratory Medicine 2014 9:61.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
